Post-mortem and in vivo imaging studies have found and an increase in glutamate levels in the prefrontal cortex of MDD patients [108], which could explain the reduced availability of mgluR5 in imaging studies as a results of the high concentrations of glutamate in depressive phenotypes. Here, GRM5 is linked to major depressive disorder.